NDC 51672-1402-08 - Calcipotriene and Betamethasone Dipropionate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1402
- Requested NDC
- 51672-1402-08
- Package NDCs from labels
- 51672-1402-4, 51672-1402-8, 51672-1402-08
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-07-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MINERAL OIL - Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-07-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1402-4 | Calcipotriene and Betamethasone Dipropionate | 60 g in 1 BOTTLE | SUSPENSION | 60 | 2 | |
| 51672-1402-4 | Calcipotriene and Betamethasone Dipropionate | 1 in 1 CARTON | SUSPENSION | 1 | 2 | |
| 51672-1402-8 | Calcipotriene and Betamethasone Dipropionate | 60 g in 1 BOTTLE | SUSPENSION | 60 | 2 | |
| 51672-1402-8 | Calcipotriene and Betamethasone Dipropionate | 2 in 1 CARTON | SUSPENSION | 2 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1402 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | Current NDC, Legacy NDC, 4 package rows | 20200904_1d0ab2e6-1ab1-4d3e-ad55-7fa26446f191.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Cosette Pharmaceuticals, Inc. | c9839c0a-bee5-0ef7-8933-e6231c440407 | 2022-11-15 | Adverse reactions | 826Y60901U |
| Calcipotriene | CALCIPOTRIENE | Cosette Pharmaceuticals, Inc. | 21378c25-5622-8bf7-1a8c-b05940a846a0 | 2022-11-15 | Warnings, Adverse reactions | 143NQ3779B |
| betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | Zydus Lifesciences Limited | f531da27-2435-49a3-8992-c65240c6a7fe | 2022-11-05 | 826Y60901U | |
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | Zydus Pharmaceuticals USA Inc. | 18d80661-72ad-4a83-917f-a80ce37a5568 | 2022-10-05 | Adverse reactions | 826Y60901U |
| REFRESH P.M. | MINERAL OIL, PETROLATUM | Allergan, Inc. | 24365d64-cd94-41cc-a7e1-033102d98114 | 2022-06-30 | Warnings | T5L8T28FGP |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Proficient Rx LP | 3d235926-6f17-4aa5-be82-7f1b4357e247 | 2022-06-01 | Adverse reactions | 826Y60901U |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Proficient Rx LP | f1be7c91-5408-4d31-8673-b691089aadce | 2022-04-01 | Warnings, Adverse reactions | 826Y60901U |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Padagis Israel Pharmaceuticals Ltd | e6018480-7788-472d-a2d1-ccccffcd258e | 2022-02-28 | Adverse reactions | 826Y60901U |
| ENSTILAR | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | LEO Pharma Inc. | d1193df2-d53f-4342-bd9d-d9cba7c89709 | 2021-10-18 | Warnings, Adverse reactions | 826Y60901U |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Proficient Rx LP | c6e4bf5f-f6d6-489e-9286-c30568c601b7 | 2021-01-01 | Warnings, Adverse reactions | 826Y60901U |
| calcipotriene | CALCIPOTRIENE | Prasco Laboratories | fe7cd92a-f066-4c4a-80c8-e3f929ad4181 | 2020-08-07 | Warnings, Adverse reactions | 143NQ3779B |
| GUNA-DIZZY | .ALPHA.-KETOGLUTARIC ACID - AMBERGRIS - ANAMIRTA COCCULUS SEED - CONIUM MACULATUM FLOWERING TOP - EPINEPHRINE - FUMARIC ACID - MALIC ACID - MELATONIN - MINERAL OIL - PTERIDIUM AQUILINUM ROOT - PYRIDOXINE HYDROCHLORIDE - QUINHYDRONE - QUININE - SUS SCROFA ARTERY - SUS SCROFA CEREBELLUM - SUS SCROFA PLACENTA - THIAMINE HYDROCHLORIDE - TOBACCO LEAF - | Guna spa | c5f4a798-e628-4388-a98d-7449dd92f2d6 | 2018-12-21 | Warnings | T5L8T28FGP |
| TACLONEX | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | LEO Pharma Inc. | 757c914f-dd8d-43cc-a973-212d591af4af | 2017-11-30 | Warnings, Adverse reactions | 826Y60901U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.